Validation of an automated blood culture system for sterility testing ofcell therapy products

Cytotherapy

Volumn 16, Issue 5, 2014, Pages 692-698

  Hocquet, Didier ^a,b   Sauget, Marlène ^a,b   Roussel, Sandrine ^a,b   Malugani, Caroline ^c   Pouthier, Fabienne ^b,c   Morel, Pascal ^b,c   Gbaguidi Haore, Houssein ^a,b   Bertrand, Xavier ^a,b   Grenouillet, Frédéric ^a,b  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

Automated blood culture systems; Cell therapy product; Microbial contamination; Sterility testing

Indexed keywords

CELL THERAPY AGENT; CULTURE MEDIUM;

AEROBIC CELL CULTURE; ANAEROBIC CELL CULTURE; ARTICLE; AUTOMATED BLOOD CULTURE SYSTEM; AUTOMATION; BACTEC MYCOSIS IC/F; BACTEC PLUS AEROBIC/F; BACTEC PLUS ANAEROBIC/F; COLONY FORMING UNIT; CULTURE MEDIUM; DRUG STERILITY; FUNGUS; GRAM POSITIVE BACTERIUM; INCUBATION TEMPERATURE; INCUBATION TIME; MICROORGANISM DETECTION; NONHUMAN; NUTRITIONAL REQUIREMENT; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; SKIN FLORA; VALIDATION PROCESS; YEAST; BIOLOGICAL THERAPY; HUMAN; INSTRUMENT STERILIZATION; PROCEDURES;

BACTERIA (MICROORGANISMS); FUNGI; POSIBACTERIA; PROPIONIBACTERIUM ACNES;

CELL- AND TISSUE-BASED THERAPY; CULTURE MEDIA; HUMANS; STERILIZATION;

EID: 84897960271     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2013.09.005     Document Type: Article

References (21)

1. Almeida I.D., Schmalfuss T., Rohsig L.M., Goldani L.Z. Autologous transplant: microbial contamination of hematopoietic stem cell products. Braz J Infect Dis 2012, 16:345-350.
2. Klein M.A., Kadidlo D., McCullough J., McKenna D.H., Burns L.J. Microbial contamination of hematopoietic stem cell products: incidence and clinical sequelae. Biol Blood Marrow Transplant 2006, 12:1142-1149.
3. Kamble R., Pant S., Selby G.B., Kharfan-Dabaja M.A., Sethi S., Kratochvil K., et al. Microbial contamination of hematopoietic progenitor cell grafts-incidence, clinical outcome, and cost-effectiveness: an analysis of 735 grafts. Transfusion 2005, 45:874-878.
4. Martinière K., Lucas S., Zorzi P. [Events and adverse reactions in biovigilance: descriptive analysis of French national data following a four-year practical experience]. Transfus Clin Biol 2008, 15:179-189. [in French].
5. Rapport d'activité biovigilance 2011 2012, ANSM, Paris.
6. Tomblyn M., Chiller T., Einsele H., Gress R., Sepkowitz K., Storek J., et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 2009, 15:1143-1238.
7. ContrÔle microbiologique des produits cellulaires 2.6.27. In: European Directorate for the Quality of Medicines & HealthCare (EDQM), editor. European Pharmacopeia. 7th ed. 2011, Strasbourg, France.
8. Huyghe G, Kahn C, Sabatini C, Panterne B, Mouillot L, Tissier M-H. Études collaboratives pour le contrÔle bactériologiquedes produits cellulaires: bilan de 7 études-SFTS 2007. 2007. Accessed on March 5, 2013. http://ansm.sante.fr/2007.
9. Khuu H.M., Stock F., McGann M., Carter C.S., Atkins J.W., Murray P.R., et al. Comparison of automated culture systems with a CFR/USP-compliant method for sterility testing of cell-therapy products. Cytotherapy 2004, 6:183-195.
10. Khuu H.M., Patel N., Carter C.S., Murray P.R., Read E.J. Sterility testing of cell therapy products: parallel comparison of automated methods with a CFR-compliant method. Transfusion 2006, 46:2071-2082.
11. Liu C, Weber C, Sempek DS, Grossman BJ, Burnham CA. Sterility testing of apheresis hematopoietic progenitor cell products using an automated blood culture system [published online ahead of print February 25, 2013]. Transfusion.
12. Mastronardi C., Yang L., Halpenny M., Toye B., Ramirez-Arcos S. Evaluation of the sterility testing process of hematopoietic stemcells at Canadian Blood Services. Transfusion 2012, 52:1778-1784.
13. Wieser A., Schneider L., Jung J., Schubert S. MALDI-TOF MS in microbiological diagnostics-identification of microorganisms and beyond. Appl Microbiol Biotechnol 2012, 93:965-974.
14. Horvath L.L., George B.J., Murray C.K., Harrison L.S., Hospenthal D.R. Direct comparison of the BACTEC 9240 and BacT/ALERT 3D automated blood culture systems for candida growth detection. JClin Microbiol 2004, 42:115-118.
15. Parveen S., Kaur S., David S.A., Kenney J.L., McCormick W.M., Gupta R.K. Evaluation of growth based rapid microbiological methods for sterility testing of vaccines and other biological products. Vaccine 2011, 29:8012-8023.
16. Larrea L., de la Rubia J., Soler M., Ribas P., Fernandez J., Picon I., et al. Quality control of bacterial contamination in autologous peripheral blood stem cells for transplantation. Haematologica 2004, 89:1232-1237.
17. Webb I.J., Coral F.S., Andersen J.W., Elias A.D., Finberg R.W., Nadler L.M., et al. Sources and sequelae of bacterial contamination of hematopoietic stem cell components: implications for the safety of hematotherapy and graft engineering. Transfusion 1996, 36:782-788.
18. Schwella N., Rick O., Heuft H.G., Miksits K., Zimmermann R., Zingsem J., et al. Bacterial contamination of autologous bone marrow: reinfusion of culture-positive grafts does not result in clinical sequelae during the posttransplantation course. Vox Sang 1998, 74:88-94.
19. Nifong T.P., Ehmann W.C., Mierski J.A., Domen R.E., Rybka W.B. Favorable outcome after infusion of coagulase-negative staphylococci-contaminated peripheral blood hematopoietic cells for autologous transplantation. Arch Pathol Lab Med 2003, 127:e19-e21.
20. Karunakaran R., Raja N.S., Quek K.F., Hoe V.C.W., Navaratnam P. Evaluation of the routine use of the anaerobic bottle when using the BACTEC blood culture system. JMicrobiol Immunol Infect 2007, 40:445-449.
21. Pope C.F., Gillespie S.H., Moore J.E., McHugh T.D. Approaches to measure the fitness of Burkholderia cepacia complex isolates. JMed Microbiol 2010, 59(Pt 6):679-686.